Philadelphia, Pennsylvania

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Epilepsy2 trials
• Parkinson disease2 trials

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Completed3 trials
• Terminated1 trial

Lead sponsor

• AbbVie4 trials

Closed trials

• Completed

  Open-label Trial in Parkinson's Disease (PD)

  NCT04760769· Phase 3· AbbVie· Source

• Terminated

  An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

  NCT04686786· Phase 2· AbbVie· Source

• Completed

  A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

  NCT04244175· Phase 2· AbbVie· Source

• Completed

  Fixed-Dose Trial in Early Parkinson's Disease (PD)

  NCT04201093· Phase 3· AbbVie· Source